IL157588A0 - Carbamate compounds for use in preventing or treating psychotic disorders - Google Patents
Carbamate compounds for use in preventing or treating psychotic disordersInfo
- Publication number
- IL157588A0 IL157588A0 IL15758802A IL15758802A IL157588A0 IL 157588 A0 IL157588 A0 IL 157588A0 IL 15758802 A IL15758802 A IL 15758802A IL 15758802 A IL15758802 A IL 15758802A IL 157588 A0 IL157588 A0 IL 157588A0
- Authority
- IL
- Israel
- Prior art keywords
- preventing
- psychotic disorders
- carbamate compounds
- treating psychotic
- treating
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/325—Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Neurology (AREA)
- Organic Chemistry (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pain & Pain Management (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US27188901P | 2001-02-27 | 2001-02-27 | |
PCT/US2002/006119 WO2002067927A1 (en) | 2001-02-27 | 2002-02-21 | Carbamate compounds for use in preventing or treating psychotic disorders |
US10/081,761 US6541513B2 (en) | 2001-02-27 | 2002-02-21 | Carbamate compounds for use in preventing or treating psychotic disorders |
Publications (1)
Publication Number | Publication Date |
---|---|
IL157588A0 true IL157588A0 (en) | 2004-03-28 |
Family
ID=26765939
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL15758802A IL157588A0 (en) | 2001-02-27 | 2002-02-21 | Carbamate compounds for use in preventing or treating psychotic disorders |
IL157588A IL157588A (en) | 2001-02-27 | 2003-08-26 | Carbamate compounds for use in preventing or treating psychotic disorders |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL157588A IL157588A (en) | 2001-02-27 | 2003-08-26 | Carbamate compounds for use in preventing or treating psychotic disorders |
Country Status (25)
Country | Link |
---|---|
US (1) | US6541513B2 (zh) |
EP (1) | EP1401424B1 (zh) |
JP (1) | JP4276841B2 (zh) |
KR (1) | KR100886578B1 (zh) |
CN (1) | CN1262271C (zh) |
AR (1) | AR032876A1 (zh) |
AT (1) | ATE346597T1 (zh) |
AU (1) | AU2002242296B2 (zh) |
BR (1) | BR0207829A (zh) |
CA (1) | CA2439480C (zh) |
CZ (1) | CZ302412B6 (zh) |
DE (1) | DE60216457T2 (zh) |
DK (1) | DK1401424T3 (zh) |
ES (1) | ES2275844T3 (zh) |
HU (1) | HUP0303342A3 (zh) |
IL (2) | IL157588A0 (zh) |
MX (1) | MXPA03007722A (zh) |
NO (1) | NO20033801L (zh) |
NZ (1) | NZ527991A (zh) |
PL (1) | PL365021A1 (zh) |
PT (1) | PT1401424E (zh) |
RS (1) | RS51056B (zh) |
RU (1) | RU2302240C2 (zh) |
TW (1) | TWI251486B (zh) |
WO (1) | WO2002067927A1 (zh) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CZ2003445A3 (cs) * | 2000-07-21 | 2004-08-18 | Ortho@Mcneilápharmaceuticalźáinc | Karbamátové sloučeniny pro prevenci nebo léčbu neuropatické bolesti a bolesti asociované s histaminovou a migrenózní bolestí hlavy |
MXPA03007720A (es) * | 2001-02-27 | 2004-11-12 | Johnson & Johnson | Compuestos de carbamato para su uso en la prevencion o el tratamiento de transtornos de ansiedad. |
NZ527990A (en) * | 2001-02-27 | 2006-01-27 | Ortho Mcneil Pharm Inc | Carbamate compounds for use in preventing or treating neurodegenerative disorders |
RU2303445C2 (ru) | 2001-07-16 | 2007-07-27 | Орто-Макнейл Фармасьютикал, Инк. | Карбаматные соединения для применения для предотвращения или лечения невропатической боли и боли, связанной с кластерной и мигреневой головной болью |
WO2005107719A2 (en) * | 2004-05-06 | 2005-11-17 | Sandoz Ag | Pharmaceutical composition comprising hydrophobic drug having improved solubility |
AU2005335241B9 (en) * | 2005-07-26 | 2012-12-20 | Sk Biopharmaceuticals Co., Ltd. | Methods for treating substance-related disorders |
CN101568362A (zh) * | 2006-10-30 | 2009-10-28 | 詹森药业有限公司 | 治疗抑郁症的方法 |
CN101568333A (zh) * | 2006-10-31 | 2009-10-28 | 詹森药业有限公司 | 广泛性发育障碍的治疗 |
US8609849B1 (en) | 2010-11-30 | 2013-12-17 | Fox Chase Chemical Diversity Center, Inc. | Hydroxylated sulfamides exhibiting neuroprotective action and their method of use |
CN109939092B (zh) | 2013-03-12 | 2022-03-22 | 比皮艾思药物研发有限公司 | 用于预防或治疗小儿癫痫和癫痫相关综合征的苯基氨基甲酸酯化合物 |
CN105164103B (zh) * | 2013-03-12 | 2019-12-06 | 比皮艾思药物研发有限公司 | 苯基氨基甲酸酯化合物和含有其的预防或治疗记忆缺失相关疾病的组合物 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3313692A (en) * | 1958-04-21 | 1967-04-11 | Armour Pharma | Method of inducing calming and muscle relaxation with carbamates |
US3265728A (en) * | 1962-07-18 | 1966-08-09 | Armour Pharma | Substituted phenethyl carbamates |
US5492930A (en) * | 1994-04-25 | 1996-02-20 | Schering Corporation | Method and formulation for treating CNS disorders |
US5698588A (en) * | 1996-01-16 | 1997-12-16 | Yukong Limited | Halogen substituted carbamate compounds from 2-phenyl-1,2-ethanediol |
-
2002
- 2002-02-21 RU RU2003128983/14A patent/RU2302240C2/ru active
- 2002-02-21 NZ NZ527991A patent/NZ527991A/en unknown
- 2002-02-21 BR BR0207829-5A patent/BR0207829A/pt not_active Application Discontinuation
- 2002-02-21 CN CNB028089235A patent/CN1262271C/zh not_active Expired - Fee Related
- 2002-02-21 US US10/081,761 patent/US6541513B2/en not_active Expired - Lifetime
- 2002-02-21 KR KR1020037011292A patent/KR100886578B1/ko active IP Right Grant
- 2002-02-21 PL PL02365021A patent/PL365021A1/xx unknown
- 2002-02-21 JP JP2002567294A patent/JP4276841B2/ja not_active Expired - Lifetime
- 2002-02-21 RS YUP-675/03A patent/RS51056B/sr unknown
- 2002-02-21 IL IL15758802A patent/IL157588A0/xx unknown
- 2002-02-21 WO PCT/US2002/006119 patent/WO2002067927A1/en active IP Right Grant
- 2002-02-21 CZ CZ20032297A patent/CZ302412B6/cs not_active IP Right Cessation
- 2002-02-21 CA CA2439480A patent/CA2439480C/en not_active Expired - Fee Related
- 2002-02-21 AT AT02707927T patent/ATE346597T1/de active
- 2002-02-21 HU HU0303342A patent/HUP0303342A3/hu unknown
- 2002-02-21 PT PT02707927T patent/PT1401424E/pt unknown
- 2002-02-21 DE DE60216457T patent/DE60216457T2/de not_active Expired - Lifetime
- 2002-02-21 ES ES02707927T patent/ES2275844T3/es not_active Expired - Lifetime
- 2002-02-21 DK DK02707927T patent/DK1401424T3/da active
- 2002-02-21 AU AU2002242296A patent/AU2002242296B2/en not_active Ceased
- 2002-02-21 EP EP02707927A patent/EP1401424B1/en not_active Expired - Lifetime
- 2002-02-21 MX MXPA03007722A patent/MXPA03007722A/es active IP Right Grant
- 2002-02-27 AR ARP020100702A patent/AR032876A1/es unknown
- 2002-03-05 TW TW091103972A patent/TWI251486B/zh not_active IP Right Cessation
-
2003
- 2003-08-26 IL IL157588A patent/IL157588A/en not_active IP Right Cessation
- 2003-08-26 NO NO20033801A patent/NO20033801L/no not_active Application Discontinuation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL173439A0 (en) | [1,8]naphthyridin-2-ones and related compounds for the treatment of schizophrenia | |
PT2311466E (pt) | Compostos antimicrobianos e métodos para a sua utilização | |
ZA200503967B (en) | Agent for preventing or treating neuropathy | |
GB0112343D0 (en) | Well treatment | |
IL160208A0 (en) | Amidine derivatives for treating amyloidosis | |
HK1061212A1 (en) | Pyranoindazoles and their use for the treatment ofglaucoma | |
HK1067305A1 (en) | Carbamate compounds for use in preventing or treating movement disorders | |
HK1060516A1 (en) | Carbamate compounds for use in preventing or treating neurodegenerative disorders | |
PL368556A1 (en) | Methods for treating or preventing skin disorders using cd2-binding agents | |
HUP0303261A3 (en) | Carbamate compounds for use in preventing or treating bipolar disorder | |
IL157588A0 (en) | Carbamate compounds for use in preventing or treating psychotic disorders | |
IL157593A0 (en) | Carbamate compounds for use in the treatment of pain | |
HUP0303243A3 (en) | Carbamate compounds for use in preventing and treating bipolar disorder | |
EP1558238A4 (en) | BETA-HYDROXYPHENYL ALDYLAMINE AND ITS USE FOR THE TREATMENT OF GLAUCOMA | |
GB2386602B (en) | Anti-loading treatments | |
EP1419236A4 (en) | METHODS OF TREATING OR PREVENTING SCLEROSIS BY USE OF CD2-BINDING AGENTS | |
PT1698338E (pt) | S-metil-di-hidro-ziprasidona para o tratamento de distúrbios psiquiátricos | |
AU2002342188A8 (en) | Methods and compositions for treating flavivirus-mediated disease | |
ZA200307477B (en) | Carbamate compounds for use in preventing or treating movement disorders. | |
GB2397018B (en) | Combination therapy for treating disease | |
HUP0402141A3 (en) | Herbicidal composition and process for its use | |
ZA200307473B (en) | Carbamate compounds for use in preventing or treating neurodegenerative disorders. | |
EP1372630A4 (en) | AGENT FOR THE TREATMENT OF THE HYPERACTIVE BLADDER | |
TWI318876B (en) | Carbamate compounds for use in preventing or treating bipolar disorder | |
GB0130694D0 (en) | Treatment |